| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |